The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study
Abstract
It is not well known how often drug resistance, a major clinical problem, occurs early or late in the course of epilepsy and how often epilepsy follows a continuous, remitting or relapsing-remitting pattern. To provide evidence if, in fact, different patterns of evolution of drug resistance and remission exist, a prospective, long-term population-based study of 144 patients followed on the average for 37.0 years (SD 7.1, median 40.0, range 11-42) since their first seizure before the age of 16 years was performed. At the end of follow-up, 67% of 144 patients were in terminal remission, on or off antiepileptic drugs. Early remission, starting within the first year of treatment, was seen in 45 patients (31%). In 23 (16%) of them, first remission continued, uninterrupted by relapse, to terminal remission. Late remission with a mean delay of 9 years was achieved by a further 72 patients (50%), including 46 (32%) patients who achieved terminal remission without any relapse and suggested, together with 23 patients, a remitting course. Following a relapse after early or late remission, 28 (19%) patients achieved terminal remission, suggesting a remitting-relapsing pattern. Altogether 20 patients (14%) did not re-enter remission, indicating a worsening course of epilepsy. Twenty-seven (19%) patients were drug-resistant from the start to the end of follow-up. In conclusion, half the patients with childhood-onset epilepsy will eventually enter terminal remission without relapse and a fifth after relapse. One-third will have a poor long-term outcome in terms of persistent seizures after remission or without any remission ever.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Guidelines for epidemiologic studies on epilepsy
Prognosis (1993) · Epilepsia · Cited by 1,183
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 726
Self-citationFrench, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123693.82339.fc · Cited by 654
Pitkänen, A., & Sutula, T. P. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00073-x · Cited by 637
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 622
Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms
Schmidt, D., & Löscher, W. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.54904.x · Cited by 482
Self-citationEffectiveness of First Antiepileptic Drug
Kwan, P., & Brodie, M. J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.04501.x · Cited by 432
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123695.22623.32 · Cited by 407
Remission of epilepsy: results from the National General Practice Study of Epilepsy
Cockerell, O. C., Sander, J. W. A. S., Hart, Y. M., Shorvon, S. D., & Johnson, A. L. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91208-8 · Cited by 384
How long does it take for partial epilepsy to become intractable?
Berg, A. T., Langfitt, J., Shinnar, S., Vickrey, B. G., Sperling, M. R., Walczak, T., Bazil, C., Pacia, S. V., & Spencer, S. S. (2003) · Neurology · doi:10.1212/01.wnl.0000031792.89992.ec · Cited by 305
Goodridge, D. M., & Shorvon, S. D. (1983) · BMJ · doi:10.1136/bmj.287.6393.641 · Cited by 209
The Consequences of Uncontrolled Epilepsy
Sperling, M. R. (2004) · CNS Spectrums · doi:10.1017/s1092852900008464 · Cited by 201
Perceived Impact of Childhood‐onset Epilepsy on Quality of Life as an Adult
Sillanpää, M., Haataja, L., & Shinnar, S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.44203.x · Cited by 184
Self-citationRefractory epilepsy: a progressive, intractable but preventable condition?
Kwan, P., & Brodie, M. J. (2002) · Seizure · doi:10.1053/seiz.2002.0593 · Cited by 161
Disease modification in partial epilepsy
Walker, M. C., White, H. S., & Sander, J. W. A. S. (2002) · Brain · doi:10.1093/brain/awf203 · Cited by 153
Status epilepticus in a population‐based cohort with childhood‐onset epilepsy in Finland
Sillanpää, M. L., & Shinnar, S. (2002) · Annals of Neurology · doi:10.1002/ana.10286 · Cited by 123
Self-citationUnderstanding the Delay Before Epilepsy Surgery: Who Develops Intractable Focal Epilepsy and When?
Berg, A. T. (2004) · CNS Spectrums · doi:10.1017/s109285290000849x · Cited by 108
Epilepsy syndromes in patients with childhood-onset seizures in Finland
Sillanpää, M. L., Jalava, M., & Shinnar, S. (1999) · Pediatric Neurology · doi:10.1016/s0887-8994(99)00031-4 · Cited by 107
Self-citationSillanpää, M. L. (1973) · PubMed · Cited by 97
Self-citationThe clinical impact of new antiepileptic drugs after a decade of use in epilepsy
Schmidt, D. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00065-7 · Cited by 93
Self-citationNew strategies for the identification of drugs to prevent the development or progression of epilepsy
Schmidt, D., & Rogawski, M. A. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00070-0 · Cited by 71
Self-citation
Cited by
Beghi, E. (2020) · Neuroepidemiology · doi:10.1159/000503831 · Cited by 1,452
Patterns of treatment response in newly diagnosed epilepsy
Brodie, M. J., Barry, S. J. E., Bamagous, G. A., Norrie, J. D., & Kwan, P. (2012) · Neurology · doi:10.1212/wnl.0b013e3182563b19 · Cited by 931
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Self-citationKossoff, E. H., Zupec‐Kania, B. A., Amark, P. E., Ballaban‐Gil, K. R., Christina Bergqvist, A. G., Blackford, R., Buchhalter, J. R., Caraballo, R. H., Helen Cross, J., Dahlin, M. G., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01765.x · Cited by 605
Enzyme induction with antiepileptic drugs: Cause for concern?
Brodie, M. J., Mintzer, S., Pack, A. M., Gidal, B. E., Vecht, C. J., & Schmidt, D. (2013) · Epilepsia · doi:10.1111/j.1528-1167.2012.03671.x · Cited by 383
Self-citation
Metadata
- Authors
- Sillanpää, M., & Schmidt, D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-09
- Volume
- 129
- Issue
- 3
- Pages
- 617-624
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2161208527
- Cited by
- 414
- References
- 24
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.